Skip to main content
Premium Trial:

Request an Annual Quote

Vincent Zurawski


Vincent Zurawski has been named CEO of the US subsidiary of Compugen.

Zurawski will direct Compugen’s US operations, based in Princeton, N.J. He will also help develop and implement Compugen’s worldwide business strategy and lead the business and product development of the company’s drug discovery activities.

Following the co-founding of Centocor, a biotechnology company which was recently purchased by Johnson & Johnson, Zurawski founded and was CEO of Apollon, a developer of DNA-based vaccines.

Most recently, Zurawski served as director of research business development at the University of Pennsylvania School of Medicine and Health System, where he was responsible for commercializing intellectual property.

Filed under

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.